Carlo Mazzatenta

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Venues

Clinical, cosmetic and investigational dermatology

The Australasian journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Giorgia Salvia, Matteo Bevilacqua, Flavia Manzo Margiotta, Alessandra Michelucci, Giammarco Granieri, Cristian Fidanzi, Valentina Dini, Marco Romanelli, Carlo Mazzatenta
Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum. The Australasian journal of dermatology 65 (4) (2024)
Giorgia Salvia, Matteo Bevilacqua, Flavia Manzo Margiotta, Alessandra Michelucci, Giammarco Granieri, Cristian Fidanzi, Valentina Dini, Marco Romanelli, Carlo Mazzatenta
Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum. The Australasian journal of dermatology (2024)
Filomena Russo, Marco Galluzzo, Luca Stingeni, Severino Persechino, Leonardo Zichichi, Andrea Conti, Claudia Giofrè, Valentina Dini, Martina Vispi, Laura Atzori, Angelo Cattaneo, Aurora Parodi, Federico Bardazzi, Giuseppe Stinco, Paolo Dapavo, Giampiero Girolomoni, Maria Letizia Musumeci, Manuela Papini, Marina Venturini, Stefano Dastoli, Sergio Di Nuzzo, Maria-Concetta Fargnoli, Gianluca Pagnanelli, Nicoletta Bernardini, Daniele Mario Gambini, Piergiorgio Malagoli, Carlo Mazzatenta, Ketty Peris, Iris Zalaudek, Gabriella Fabbrocini, Francesco Loconsole, Camilla Vassallo, Lucia Pietroleonardo, Francesca Prignano, Chiara Franchi, Anna Maria Offidani, Claudio Bonifati, Vito Di Lernia, Giovanni Gigante, Marta Silvia Bartezaghi, Matteo Franchi, Paola Ursoleo, Elisabetta Aloisi
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study. Clinical, cosmetic and investigational dermatology 16 (2023)
Filomena Russo, Marco Galluzzo, Luca Stingeni, Severino Persechino, Leonardo Zichichi, Andrea Conti, Claudia Giofrè, Valentina Dini, Martina Vispi, Laura Atzori, Angelo Cattaneo, Aurora Parodi, Federico Bardazzi, Giuseppe Stinco, Paolo Dapavo, Giampiero Girolomoni, Maria Letizia Musumeci, Manuela Papini, Marina Venturini, Stefano Dastoli, Sergio Di Nuzzo, Maria-Concetta Fargnoli, Gianluca Pagnanelli, Nicoletta Bernardini, Daniele Mario Gambini, Piergiorgio Malagoli, Carlo Mazzatenta, Ketty Peris, Iris Zalaudek, Gabriella Fabbrocini, Francesco Loconsole, Camilla Vassallo, Lucia Pietroleonardo, Francesca Prignano, Chiara Franchi, Anna Maria Offidani, Claudio Bonifati, Vito Di Lernia, Giovanni Gigante, Marta Silvia Bartezaghi, Matteo Franchi, Paola Ursoleo, Elisabetta Aloisi
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study. Clinical, cosmetic and investigational dermatology 16 (2023)

Carlo Mazzatenta.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carlo Mazzatenta